<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>62</viewCount><searchCount>0</searchCount></scores><additional><submitter>Banerjee S</submitter><funding>BMBF</funding><funding>Alexander von Humboldt</funding><funding>European Research Council</funding><funding>Biotechnology and Biological Sciences Research Council</funding><funding>Engineering and Physical Sciences Research Council</funding><pagination>3177-3185</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5916112</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(12)</volume><pubmed_abstract>The Cp &lt;sup>&lt;i>x&lt;/i>&lt;/sup> C-H protons in certain organometallic Rh&lt;sup>III&lt;/sup> half-sandwich anticancer complexes [(η&lt;sup>5&lt;/sup>-Cp &lt;sup>&lt;i>x&lt;/i>&lt;/sup> )Rh(&lt;i>N&lt;/i>,&lt;i>N&lt;/i>')Cl]&lt;sup>+&lt;/sup>, where Cp &lt;sup>&lt;i>x&lt;/i>&lt;/sup> = Cp*, phenyl or biphenyl-Me&lt;sub>4&lt;/sub>Cp, and &lt;i>N&lt;/i>,&lt;i>N&lt;/i>' = bipyridine, dimethylbipyridine, or phenanthroline, can undergo rapid sequential deuteration of all 15 Cp* methyl protons in aqueous media at ambient temperature. DFT calculations suggest a mechanism involving abstraction of a Cp* proton by the Rh-hydroxido complex, followed by sequential H/D exchange, with the Cp* rings behaving like dynamic molecular 'twisters'. The calculations reveal the crucial role of p&lt;sub>π&lt;/sub> orbitals of &lt;i>N&lt;/i>,&lt;i>N&lt;/i>'-chelated ligands in stabilizing deprotonated Cp &lt;sup>&lt;i>x&lt;/i>&lt;/sup> ligands, and also the accessibility of Rh&lt;sup>I&lt;/sup>-fulvene intermediates. They also provide insight into why biologically-inactive complexes such as [(Cp*)Rh&lt;sup>III&lt;/sup>(en)Cl]&lt;sup>+&lt;/sup> and [(Cp*)Ir&lt;sup>III&lt;/sup>(bpy)Cl]&lt;sup>+&lt;/sup> do not have activated Cp* rings. The thiol tripeptide glutathione (γ-l-Glu-l-Cys-Gly, GSH) and the activated dienophile &lt;i>N&lt;/i>-methylmaleimide, (NMM) did not undergo addition reactions with the proposed Rh&lt;sup>I&lt;/sup>-fulvene, although they were able to control the extent of Cp* deuteration. We readily trapped and characterized Rh&lt;sup>I&lt;/sup>-fulvene intermediates by Diels-Alder [4+2] cyclo-addition reactions with the natural biological dienes isoprene and conjugated (9&lt;i&gt;Z&lt;/i>,11&lt;i>E&lt;/i>)-linoleic acid in aqueous media, including cell culture medium, the first report of a Diels-Alder reaction of a metal-bound fulvene in aqueous solution. These findings will introduce new concepts into the design of organometallic Cp* anticancer complexes with novel mechanisms of action.</pubmed_abstract><journal>Chemical science</journal><pubmed_title>New activation mechanism for half-sandwich organometallic anticancer complexes.</pubmed_title><pmcid>PMC5916112</pmcid><funding_grant_id>EP/F034210/1</funding_grant_id><funding_grant_id>247450</funding_grant_id><funding_grant_id>EP/J000302/1</funding_grant_id><funding_grant_id>1679369</funding_grant_id><funding_grant_id>BB/P021875/1</funding_grant_id><funding_grant_id>BB/R022399/1</funding_grant_id><funding_grant_id>05K13UK2</funding_grant_id><funding_grant_id>EP/N021630/1</funding_grant_id><funding_grant_id>1837376</funding_grant_id><pubmed_authors>Banerjee S</pubmed_authors><pubmed_authors>Habtemariam A</pubmed_authors><pubmed_authors>Chen F</pubmed_authors><pubmed_authors>O'Connor PB</pubmed_authors><pubmed_authors>Song L</pubmed_authors><pubmed_authors>Soldevila-Barreda JJ</pubmed_authors><pubmed_authors>Wolny JA</pubmed_authors><pubmed_authors>Clarkson GJ</pubmed_authors><pubmed_authors>Prokes I</pubmed_authors><pubmed_authors>Romero-Canelon I</pubmed_authors><pubmed_authors>Sadler PJ</pubmed_authors><pubmed_authors>Schunemann V</pubmed_authors><pubmed_authors>Wootton CA</pubmed_authors><view_count>62</view_count></additional><is_claimable>false</is_claimable><name>New activation mechanism for half-sandwich organometallic anticancer complexes.</name><description>The Cp &lt;sup>&lt;i>x&lt;/i>&lt;/sup> C-H protons in certain organometallic Rh&lt;sup>III&lt;/sup> half-sandwich anticancer complexes [(η&lt;sup>5&lt;/sup>-Cp &lt;sup>&lt;i>x&lt;/i>&lt;/sup> )Rh(&lt;i>N&lt;/i>,&lt;i>N&lt;/i>')Cl]&lt;sup>+&lt;/sup>, where Cp &lt;sup>&lt;i>x&lt;/i>&lt;/sup> = Cp*, phenyl or biphenyl-Me&lt;sub>4&lt;/sub>Cp, and &lt;i>N&lt;/i>,&lt;i>N&lt;/i>' = bipyridine, dimethylbipyridine, or phenanthroline, can undergo rapid sequential deuteration of all 15 Cp* methyl protons in aqueous media at ambient temperature. DFT calculations suggest a mechanism involving abstraction of a Cp* proton by the Rh-hydroxido complex, followed by sequential H/D exchange, with the Cp* rings behaving like dynamic molecular 'twisters'. The calculations reveal the crucial role of p&lt;sub>π&lt;/sub> orbitals of &lt;i>N&lt;/i>,&lt;i>N&lt;/i>'-chelated ligands in stabilizing deprotonated Cp &lt;sup>&lt;i>x&lt;/i>&lt;/sup> ligands, and also the accessibility of Rh&lt;sup>I&lt;/sup>-fulvene intermediates. They also provide insight into why biologically-inactive complexes such as [(Cp*)Rh&lt;sup>III&lt;/sup>(en)Cl]&lt;sup>+&lt;/sup> and [(Cp*)Ir&lt;sup>III&lt;/sup>(bpy)Cl]&lt;sup>+&lt;/sup> do not have activated Cp* rings. The thiol tripeptide glutathione (γ-l-Glu-l-Cys-Gly, GSH) and the activated dienophile &lt;i>N&lt;/i>-methylmaleimide, (NMM) did not undergo addition reactions with the proposed Rh&lt;sup>I&lt;/sup>-fulvene, although they were able to control the extent of Cp* deuteration. We readily trapped and characterized Rh&lt;sup>I&lt;/sup>-fulvene intermediates by Diels-Alder [4+2] cyclo-addition reactions with the natural biological dienes isoprene and conjugated (9&lt;i&gt;Z&lt;/i>,11&lt;i>E&lt;/i>)-linoleic acid in aqueous media, including cell culture medium, the first report of a Diels-Alder reaction of a metal-bound fulvene in aqueous solution. These findings will introduce new concepts into the design of organometallic Cp* anticancer complexes with novel mechanisms of action.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Mar</publication><modification>2024-11-20T08:47:14.654Z</modification><creation>2019-03-26T23:36:28Z</creation></dates><accession>S-EPMC5916112</accession><cross_references><pubmed>29732100</pubmed><doi>10.1039/c7sc05058e</doi></cross_references></HashMap>